Article Details

Bangavax gets DGDA nod for human trials - The Business Standard

Retrieved on: 2022-07-17 16:39:25

Tags for this article:

Click the tags to see associated articles and topics

Bangavax gets DGDA nod for human trials - The Business Standard. View article details on hiswai:

Excerpt

... received approval from the Directorate General of Drug Administration (DGDA) to begin human trials of its mRNA Covid-19 vaccine "Bangavax".

Article found on: www.tbsnews.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up